139
Views
4
CrossRef citations to date
0
Altmetric
Original Articles

Analysis of the Differences in Ocular Surface Damage and Inflammatory Signs between Healthy and Evaporative Dry Eye Participants

, OD, MScORCID Icon, , OD, MSc, PhDORCID Icon, , OD, MScORCID Icon, , OD, MSc, PhDORCID Icon, , OD, MSc, PhD & , OD, PhDORCID Icon
Pages 970-977 | Received 20 Jan 2022, Accepted 04 May 2022, Published online: 19 May 2022

References

  • Stapleton F, Alves M, Bunya VY, et al. TFOS DEWS II epidemiology report. Ocul Surf. 2017;15:334–365. doi:10.1016/j.jtos.2017.05.003.
  • Tong L, Chaurasia SS, Mehta JS, et al. Screening for meibomian gland disease: its relation to dry eye subtypes and symptoms in a tertiary referral clinic in Singapore. Invest Ophthalmol Vis Sci. 2010;51:3449–3454. doi:10.1167/iovs.09-4445.
  • Lemp MA, Crews LA, Bron AJ, et al. Distribution of aqueous-deficient and evaporative dry eye in a clinic-based patient cohort: a retrospective study. Cornea. 2012;31:472–478. doi:10.1097/ICO.0b013e318225415a.
  • Craig JP, Nichols KK, Akpek EK, et al. TFOS DEWS II definition and classification report. Ocul Surf. 2017;15:276–283. doi:10.1016/j.jtos.2017.05.008.
  • Nelson JD, Shimazaki J, Benitez-del-Castillo JM, et al. The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. Invest Ophthalmol Vis Sci. 2011;52:1930–1937. doi:10.1167/iovs.10-6997b.
  • Wolffsohn JS, Arita R, Chalmers R, et al. TFOS DEWS II diagnostic methodology report. Ocul Surf. 2017;15:539–574. doi:10.1016/j.jtos.2017.05.001.
  • Terry RL, Schnider CM, Holden BA, et al. CCLRU standards for success of daily and extended wear contact lenses. Optom Vis Sci. 1993;70:234–243. doi:10.1097/00006324-199303000-00011.
  • Tomlinson A, Bron AJ, Korb DR, et al. The international workshop on meibomian gland dysfunction: report of the diagnosis subcommittee. Invest Ophthalmol Vis Sci. 2011;52:2006–2049. doi:10.1167/iovs.10-6997f.
  • Garcia-Resua C, Santodomingo-Rubido J, Lira M, et al. Clinical assessment of the lower tear meniscus height. Ophthalmic Physiol Opt. 2009;29:487–496. doi:10.1111/j.1475-1313.2009.00634.x.
  • Garcia-Resua C, Pena-Verdeal H, Remeseiro B, et al. Correlation between tear osmolarity and tear meniscus. Optom Vis Sci. 2014;91:1419–1429. doi:10.1097/OPX.0000000000000412.
  • Miller KL, Walt JG, Mink DR, et al. Minimal clinically important difference for the ocular surface disease index. Arch Ophthalmol. 2010;128:94–101. doi:10.1001/archophthalmol.2009.356.
  • Guillon J-P. Non-invasive tearscope plus routine for contact lens fitting. Contact Lens Anterior Eye. 1998;21:S31–S40. doi:10.1016/S1367-0484(98)80035-0.
  • Ray WA, O’Day DM. Statistical analysis of multi-eye data in ophthalmic research. Invest Ophthalmol Vis Sci. 1985;26:1186–1188.
  • Schiffman RM, Christianson MD, Jacobsen G, et al. Reliability and validity of the ocular surface disease index. Arch Ophthalmol. 2000;118:615–621. doi:10.1001/archopht.118.5.615.
  • Bron AJ, Tomlinson A, Foulks GN, et al. Rethinking dry eye disease: a perspective on clinical implications. Ocul Surf. 2014;12:S1–S31. doi:10.1016/j.jtos.2014.02.002.
  • Johnson ME, Murphy PJ. The effect of instilled fluorescein solution volume on the values and repeatability of TBUT measurements. Cornea. 2005;24:811–817. doi:10.1097/01.ico.0000154378.67495.40.
  • Begley CG, Himebaugh N, Renner D, et al. Tear breakup dynamics: a technique for quantifying tear film instability. Optom Vis Sci. 2006;83:15–21. doi:10.1097/01.opx.0000195569.36185.fd.
  • Cox SM, Nichols KK, Nichols JJ. Agreement between automated and traditional measures of tear film breakup. Optom Vis Sci. 2015;92:e257–263. doi:10.1097/OPX.0000000000000648.
  • Garcia-Resua C, Pena-Verdeal H, Minones M, et al. Interobserver and intraobserver repeatability of lipid layer pattern evaluation by two experienced observers. Cont Lens Anterior Eye. 2014;37:431–437. doi:10.1016/j.clae.2014.07.006.
  • Pult H, Riede-Pult B. Comparison of subjective grading and objective assessment in meibography. Cont Lens Anterior Eye. 2013;36:22–27. doi:10.1016/j.clae.2012.10.074.
  • Bron AJ, Evans VE, Smith JA. Grading of corneal and conjunctival staining in the context of other dry eye tests. Cornea. 2003;22:640–650. doi:10.1097/00003226-200310000-00008.
  • Pult H, Riede-Pult BH. Non-contact meibography: keep it simple but effective. Cont Lens Anterior Eye. 2012;35:77–80. doi:10.1016/j.clae.2011.08.003.
  • Arita R, Itoh K, Inoue K, et al. Noncontact infrared meibography to document age-related changes of the meibomian glands in a normal population. Ophthalmology. 2008;115:911–915. doi:10.1016/j.ophtha.2007.06.031.
  • Arita R, Itoh K, Maeda S, et al. Efficacy of diagnostic criteria for the differential diagnosis between obstructive meibomian gland dysfunction and aqueous deficiency dry eye. Jpn J Ophthalmol. 2010;54:387–391. doi:10.1007/s10384-010-0858-1.
  • Armstrong RA, Davies LN, Dunne MC, et al. Statistical guidelines for clinical studies of human vision. Ophthalmic Physiol Opt. 2011;31:123–136. doi:10.1111/j.1475-1313.2010.00815.x.
  • Dunn G. Design and analysis of reliability studies. Stat Methods Med Res. 1992;1:123–157. doi:10.1177/096228029200100202.
  • Bron AJ, de Paiva CS, Chauhan SK, et al. TFOS DEWS II pathophysiology report. Ocul Surf. 2017;15:438–510. doi:10.1016/j.jtos.2017.05.011.
  • Nichols KK, Nichols JJ, Mitchell GL. The lack of association between signs and symptoms in patients with dry eye disease. Cornea. 2004;23:762–770. doi:10.1097/01.ico.0000133997.07144.9e.
  • Pult H. Relationships between meibomian gland loss and age, sex, and dry eye. Eye Contact Lens. 2018;44(Suppl 2):S318–S324. doi:10.1097/ICL.0000000000000467.
  • Borrelli M, Frings A, Geerling G, et al. Gender-specific differences in signs and symptoms of dry eye disease. Current Eye Research. 2021;46:294–301. doi:10.1080/02713683.2020.1801758.
  • Crespo-Treviño RR, Salinas-Sánchez AK, Amparo F, et al. Comparative of meibomian gland morphology in patients with evaporative dry eye disease versus non-dry eye disease. Scientific Reports. 2021;11:1–8.
  • Shimazaki J, Sakata M, Tsubota K. Ocular surface changes and discomfort in patients with meibomian gland dysfunction. Arch Ophthalmol. 1995;113:1266–1270. doi:10.1001/archopht.1995.01100100054027.
  • Alghamdi YA, Mercado C, McClellan AL, et al. The epidemiology of meibomian gland dysfunction in an elderly population. Cornea. 2016;35:731. doi:10.1097/ICO.0000000000000815.
  • Viso E, Gude F, Rodríguez-Ares MT. The association of meibomian gland dysfunction and other common ocular diseases with dry eye: a population-based study in Spain. Cornea. 2011;30:1–6. doi:10.1097/ICO.0b013e3181da5778.
  • Rico-del-Viejo L, Benítez-del-Castillo JM, Gómez-Sanz FJ, et al. The influence of meibomian gland loss on ocular surface clinical parameters. Contact Lens Anterior Eye. 2019;42:562–568. doi:10.1016/j.clae.2019.04.004.
  • Galor A, Feuer W, Lee DJ, et al. Ocular surface parameters in older male veterans. Invest Ophthalmol Vis Sci. 2013;54:1426–1433. doi:10.1167/iovs.12-10819.
  • Robin M, Liang H, Rabut G, et al. The role of meibography in the diagnosis of meibomian gland dysfunction in ocular surface diseases. Trans Vision Sci Technol. 2019;8:6. doi:10.1167/tvst.8.6.6.
  • Xiao J, Adil MY, Chen X, et al. Functional and morphological evaluation of meibomian glands in the assessment of meibomian gland dysfunction subtype and severity. American Journal of Ophthalmology. 2020;209:160–167. doi:10.1016/j.ajo.2019.09.005.
  • Jie Y, Xu L, Wu Y, et al. Prevalence of dry eye among adult Chinese in the Beijing eye study. Eye. 2009;23:688–693. doi:10.1038/sj.eye.6703101.
  • Llorens-Quintana C, Rico-del-Viejo L, Syga P, et al. Meibomian gland morphology: the influence of structural variations on gland function and ocular surface parameters. Cornea. 2019;38:1506–1512. doi:10.1097/ICO.0000000000002141.
  • Willcox MDP, Argueso P, Georgiev GA, et al. TFOS DEWS II tear film report. Ocul Surf. 2017;15:366–403. doi:10.1016/j.jtos.2017.03.006.
  • Song H, Zhang M, Hu X, et al. Correlation analysis of ocular symptoms and signs in patients with dry eye. 2017; 2017.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.